This brand name is authorized in Austria, Croatia, France, Japan, Malta, Netherlands, New Zealand, Poland, Singapore, Spain, Tunisia, UK.
The drug RABIPUR contains one active pharmaceutical ingredient (API):
1
|
UNII
I0V66KI1LD - RABIES VIRUS
|
Below package inserts are available for further reading:
| Document | Type | Information Source | |
|---|---|---|---|
| RABIPUR Powder and solvent for solution for injection | MPI, EU: SmPC | Medicines & Healthcare Products Regulatory Agency (GB) |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| J07BG01 | Rabies, inactivated, whole virus | J Antiinfectives for systemic use → J07 Vaccines → J07B Viral vaccines → J07BG Rabies vaccines |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| ES | Centro de información online de medicamentos de la AEMPS | 80926 |
| FR | Base de données publique des médicaments | 66800338 |
| GB | Medicines & Healthcare Products Regulatory Agency | 341977 |
| HR | Agencija za lijekove i medicinske proizvode | HR-H-512237923 |
| JP | 医薬品医療機器総合機構 | 6313400E1025 |
| MT | Medicines Authority | AA770/09201 |
| NL | Z-Index G-Standaard, PRK | 95796 |
| NZ | Medicines and Medical Devices Safety Authority | 16280 |
| PL | Rejestru Produktów Leczniczych | 100057149, 100349834 |
| SG | Health Sciences Authority | 13202P |
| TN | Direction de la Pharmacie et du Médicament | 1363011H |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.